ArticleMolecular imaging and biology2022

Clinical Utility of F-18 Labeled Fibroblast Activation Protein Inhibitor (FAPI) for Primary Staging in Lung Adenocarcinoma: a Prospective Study.

Youcai Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.